Jiuping Ji

Medicine · Health Sciences

28h-index6.8kcitations197works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PARP inhibition in cancer therapy(130), Cancer therapeutics and mechanisms(42), DNA Repair Mechanisms(33), Neutropenia and Cancer Infections(28), Ovarian cancer diagnosis and treatment(20)

Publications197 total

Supplemental Figure S4 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2025Open Access
Supplemental Figure S6 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2025Open Access
Supplemental Figure S3 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2025Open Access
Supplemental Figure S2 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2025Open Access
Supplemental Table S1 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2025Open Access
Supplemental Figure S1 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2025Open Access
Supplemental Methods 1 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2025Open Access
Supplemental Figure S5 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2025Open Access
Supplemental Table S2 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2025Open Access
Abstract CT120: Phase 1 trial of bortezomib and clofarabine combination in adults with refractory solid tumors
Cancer Research·2024
Abstract B138: Pharmacodynamics-driven phase 2 trial of talazoparib in patients with advanced solid tumors and aberrations in genes involved in DNA damage response
Molecular Cancer Therapeutics·2023· 1 cited
Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
Cancer Chemotherapy and Pharmacology·2023· 5 citedOpen Access
Supplemental Table S2 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2023Open Access
Supplemental Figure S5 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2023Open Access
Supplemental Figure S5 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2023Open Access
Supplemental Figure S1 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2023Open Access
Supplemental Table S2 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2023Open Access
Data from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2023Open Access
Supplemental Figure S4 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2023Open Access
Supplemental Figure S1 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models
2023Open Access
page 1 of 10Next →

Frequent Co-authors

James H. Doroshow(29), Robert J. Kinders(22), Alice P. Chen(21), Ralph E. Parchment(20), Yiping Zhang(17), Shivaani Kummar(16), Larry Rubinstein(13), Yves Pommier(12), Joseph E. Tomaszewski(12), Jan H. Beumer(6), Seth M. Steinberg(5), Melinda G. Hollingshead(5), Deborah Allen(5), Geraldine O’Sullivan Coyne(5), Scott H. Kaufmann(5), Junko Murai(4), Shunichi Takeda(4), Anthony J. Murgo(4), Jerry M. Collins(4), Lee J. Helman(4)